Literature DB >> 975058

Differentiation of early mouse embryonic and teratocarcinoma cells in vitro: plasminogen activator production.

M I Sherman, S Strickland, E Reich.   

Abstract

Cultured mouse blastocysts produce plasminogen activator, a protease that converts the zymogen plasminogen into the trypsin-like enzyme, plasmin. We have fractionated the blastocyst and cultured the constituent cell types. Trophoblast outgrowths free of inner cell mass derivatives secrete plasminogen activator during a time period that closely parallels the invasive phase of trophoblast cells in utero. Isolated inner cell masses also produce plasminogen activator; further fractionation of the inner cell mass as well as studies with primary cultures obtained from midgestation tissues demonstrate that enzyme formation is restricted entirely to parietal endoderm cells. Secretion of the enzyme may facilitate the migration of parietal endoderm cells along the trophoblast layer as the yolk sac cavity enlarges during gestation. F9 embryonal carcinoma cells do not secrete detectable amounts of plasminogen activator. However, when these cells are induced to differentiate, the resulting parietal endoderm-like cells are capable of producing the enzyme. These results are consistent with previous findings suggesting that plasminogen activator production may be a characteristic of invasive and/or migratory cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 975058

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Proteolytic activity of first trimester human placenta: localization of interstitial collagenase in villous and extravillous trophoblast.

Authors:  U M Moll; B L Lane
Journal:  Histochemistry       Date:  1990

2.  Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.

Authors:  M Zimmerman; J P Quigley; B Ashe; C Dorn; R Goldfarb; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

3.  Modulation of granule cell migration by a glia-derived protein.

Authors:  J Lindner; J Guenther; H Nick; G Zinser; H Antonicek; M Schachner; D Monard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Polyoma virus infection of retinoic acid-induced differentiated teratocarcinoma cells.

Authors:  F K Fujimura; P E Silbert; W Eckhart; E Linney
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

5.  Differentiation as a requirement for simian virus 40 gene expression in F-9 embryonal carcinoma cells.

Authors:  S Segal; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  Activities of proteinases and of a proteinase B inhibitor in tumors of the human uterus.

Authors:  H Geyer; E G Afting; P Toussi
Journal:  Arch Gynecol       Date:  1984

7.  [The prognostic importance of urinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma].

Authors:  B Hundsdorfer; H-F Zeilhofer; K P Bock; P Dettmar; M Schmitt; H-H Horch
Journal:  Mund Kiefer Gesichtschir       Date:  2004-02-06

8.  [Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma].

Authors:  B Hundsdorfer; H-F Zeilhofer; K P Bock; P Dettmar; M Schmitt; H-H Horch
Journal:  Mund Kiefer Gesichtschir       Date:  2004-02-06

9.  The kinetics of induction of Hox1.6 and C-jun mRNA during three different ways of inducing differentiation in teratocarcinoma F9 cells.

Authors:  S A Iwai; Y Nishina; M Kosaka; T Sumi; T Doi; M Sakuda; Y Nishimune
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-06       Impact factor: 2.416

10.  Characterization of a new human cell line derived from a xenografted embryonal carcinoma.

Authors:  C Cotte; D Raghavan; R A McIlhinney; P Monaghan
Journal:  In Vitro       Date:  1982-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.